Lumexa Imaging (NASDAQ:LMRI) Trading Up 11.9% on Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price was up 11.9% during mid-day trading on Tuesday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging traded as high as $12.98 and last traded at $12.93. Approximately 133,065 shares changed hands during trading, a decline of 79% from the average daily volume of 629,993 shares. The stock had previously closed at $11.55.

Institutional Trading of Lumexa Imaging

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. TD Asset Management Inc acquired a new position in Lumexa Imaging in the fourth quarter worth approximately $1,264,000. Goldman Sachs Group Inc. acquired a new stake in shares of Lumexa Imaging during the 4th quarter valued at $18,870,000. Geode Capital Management LLC bought a new stake in shares of Lumexa Imaging during the 4th quarter worth $1,548,000. Seven Grand Managers LLC acquired a new position in shares of Lumexa Imaging in the 4th quarter worth $11,942,000. Finally, Assetmark Inc. acquired a new stake in shares of Lumexa Imaging during the fourth quarter worth $36,000.

Lumexa Imaging Trading Up 21.3%

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).